Schneider, M., Muley, T., Kahn, N., Warth, A., Thomas, M., Herth, F., . . . Meister, M. (2016). Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma. OncoTarget, 7(44), . https://doi.org/10.18632/oncotarget.12474
Chicago-Zitierstil (17. Ausg.)Schneider, Marc, Thomas Muley, Nicolas Kahn, Arne Warth, Michael Thomas, Felix Herth, Hendrik Dienemann, und Michael Meister. "Glycodelin Is a Potential Novel Follow-up Biomarker for Malignant Pleural Mesothelioma." OncoTarget 7, no. 44 (2016). https://doi.org/10.18632/oncotarget.12474.
MLA-Zitierstil (9. Ausg.)Schneider, Marc, et al. "Glycodelin Is a Potential Novel Follow-up Biomarker for Malignant Pleural Mesothelioma." OncoTarget, vol. 7, no. 44, 2016, https://doi.org/10.18632/oncotarget.12474.